(Photo credit: Brock University).
Oklahoma lawmakers will take a closer look at how medical marijuana products are tested and regulated during an interim legislative study scheduled for October.
The study, led by State Representative Jacob Rosecrants (D-Norman), will focus on whether the state’s current testing and oversight system is providing patients with reliable information about the marijuana products they purchase.
Among the issues expected to be reviewed are laboratory standards, compliance rules, product recalls and the mechanisms used by regulators to oversee the medical marijuana industry.
Rosecrants said bringing together patients, regulators, testing laboratories and marijuana businesses could help lawmakers identify weaknesses in the current system and determine where changes may be warranted.
“Medical marijuana patients in Oklahoma deserve to know that the products they rely on are safe, accurately tested, and held to consistent standards,” said Rosecrants.
He said the discussion will provide an opportunity to evaluate what is working under the existing framework while considering ways to improve safety, accountability and public confidence in the program.
Oklahoma has one of the nation’s largest medical marijuana markets, making testing accuracy and consistent regulatory standards particularly important for patients and businesses operating within the system.
The interim study is scheduled for October 13 from 9:30 a.m. to 12:30 p.m.
Related posts:
Oregon Marijuana Regulators Seek 75% Fee Increase, Warn of $17.25 Million Shortfall and 53 Potential...
Massachusetts Marijuana Legalization and Repeal Campaigns Raise $5 Million, Spend $4.8 Million in 20...
